title: From whole exome sequencing to patient-specific therapy: another example of how basic research pays off in patient care.
authors.affiliation: Heart Center, Department of Cardiology, Academic Medical Centre, Amsterdam, The Netherlands (A.M.W.) Princess Al-Jawhara Al-Brahim Centre of Excellence in Research of Hereditary Disorders, Jeddah, Saudi Arabia (A.M.W.).
authors.forename: Arthur A M
authors.initials: AA
authors.lastname: Wilde
authors.affiliation: Department of Cardiology, Tel-Aviv Sourasky Medical Center and Sackler School of Medicine, Tel-Aviv University, Israel (S.V.).
authors.forename: Sami
authors.initials: S
authors.lastname: Viskin
mesh_terms: D000200:Action Potentials / Q000187:drug effects*; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases / Q000235:genetics*; D006801:Humans; D008297:Male; D009154:Mutation; D009419:Nerve Tissue Proteins / Q000235:genetics*; D026902:Potassium Channel Blockers / Q000627:therapeutic use*; D015221:Potassium Channels / Q000235:genetics*; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014693:Ventricular Fibrillation / Q000235:genetics* / Q000503:physiopathology*
chemical_list: D009419:Nerve Tissue Proteins; D026902:Potassium Channel Blockers; D015221:Potassium Channels; D014665:Vasodilator Agents; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
keywords: Editorials; arrhythmia; genetic testing; potassium channels; repolarization; sudden cardiac death; ventricular fibrillation